TransgenicGroup

Japan Listed
Provider of drug discovery support and investment consulting services

About TransgenicGroup

TransgenicGroup is a publicly listed company based in Japan. TransgenicGroup offers products and services including Gene Modified Animals and Investment Advisory. Its focus areas include Medical Research Labs. Its legal entity is TRANSGENIC GROUP INC.

Company details

Provider of drug discovery support and investment consulting services. It offers seamless services across all stages of drug development, from early-stage research to clinical trials, leveraging expertise in gene modification and related technologies. The investment consulting arm provides advice and support in business succession, restructuring, and mergers and acquisitions. This dual approach allows the company to contribute to advancements in pharmaceutical research and support the growth of businesses in various sectors.

  • Headquarters Japan
  • Stage Public
  • Sectors
    Healthcare
  • Website category Health · Biotechnology and Pharmaceuticals
  • Website transgenic-group.co.jp
  • Legal Name Transgenic Group Inc

Products & Services of TransgenicGroup

TransgenicGroup offers a comprehensive portfolio of products and services, including Gene Modified Animals and Investment Advisory.

Gene Modified Animals
Biotechnology Services

Gene modified animals are supplied for research purposes in drug discovery.

Investment Advisory
Consulting Services

Advice on business succession and M&A is provided to support enterprise needs.

Web traffic of TransgenicGroup

The website of TransgenicGroup (transgenic-group.co.jp) receives about 5.4K visits a month and ranks #2,345,414 among all websites worldwide, #3,204 in Biotechnology and Pharmaceuticals.

  • Monthly visits
    5.4K

    ▼ 9.4% vs previous month

  • Unique visitors
    2.8K

    per month

  • Global rank
    #2,345,414

    among all websites

  • Category rank
    #3,204

    Health · Biotechnology and Pharmaceuticals

Similar websites

Websites whose visitors overlap most with TransgenicGroup. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
genscript.jp
genscript.jp
100%
#1,512,314–
orthomedico.jp
orthomedico.jp
95%
#1,718,435–
crisp-bio.blog.jp
crisp-bio.blog.jp
87%
#3,581,157–
transgenic.co.jp
85%
3.7K#3,798,437View details
sdg-ing.com
sdg-ing.com
23%
#1,795,723–
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about TransgenicGroup

TransgenicGroup is headquartered in Japan.

Provider of drug discovery support and investment consulting services. It offers seamless services across all stages of drug development, from early-stage research to clinical trials, leveraging expertise in gene modification and related technologies. The investment consulting arm provides advice and support in business succession, restructuring, and mergers and acquisitions. This dual approach allows the company to contribute to advancements in pharmaceutical research and support the growth of businesses in various sectors.

TransgenicGroup offers Gene Modified Animals and Investment Advisory.

TransgenicGroup operates through Transgenic Group Inc.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available